No Data
Tempus AI, Inc. (TEM) Q3 2024 Earnings Call Transcript Summary
Sony Posts Upbeat Earnings, Joins Tesla, Upstart, Doximity, Fortrea, Axon Enterprise And Other Big Stocks Moving Higher On Friday
Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting
Tempus Announces the Clinical Launch of Its Immune Profile Score Algorithmic Test
Exciting Growth Potential Ahead for Tempus AI (TEM)
Morgan Stanley Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $50
No Data
No Data
